Patent - Abbreviated New Drug Application Cases
Cases 21 - 30 of 77
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff: AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant: Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Array BioPharma Inc. v. Sandoz Inc.
as 1:2022cv01316
Counter Defendant: Array BioPharma Inc.
Counter Claimant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Sandoz Inc. et al
as 1:2022cv01124
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Sandoz Inc., Sandoz AG, Sandoz International GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Sandoz Inc.
as 1:2022cv01101
Plaintiff: ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Sandoz Inc.
as 1:2022cv00678
Plaintiff: Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. SANDOZ INC.
as 2:2022cv03044
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant: SANDOZ INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Sandoz Inc. et al
as 1:2022cv00591
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Sandoz Inc. and Sandoz International GmbH
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Genentech, Inc. v. Sandoz Inc.
as 22-1714
Plaintiff / Appellee: GENENTECH, INC. and INTERMUNE, INC.
Defendant / Appellant: SANDOZ INC. and LEK PHARMACEUTICALS, D.D.
Genentech, Inc. v. Sandoz Inc.
as 22-1595
Plaintiff / Appellant: GENENTECH, INC. and INTERMUNE, INC.
Defendant / Cross Appellant: SANDOZ INC.
Defendant / Appellee: LEK PHARMACEUTICALS, D.D.
Acerta Pharma B.V. et al v. Sandoz Inc.
as 1:2022cv00164
Plaintiff: Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?